Harvard Bioscience (HBIO) Asset Utilization Ratio (2011 - 2026)

Harvard Bioscience (HBIO) has 16 years of Asset Utilization Ratio data on file, last reported at 1.08 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 22.27% year-over-year to 1.08 in Q1 2026; TTM through Mar 2026 was 1.08, a 22.27% increase from a year earlier, with the FY2025 full-year figure at 0.84, up 17.43% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 1.08, down from 1.1 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for HBIO reached as high as 1.11 in Q2 2025 and fell as low as 0.73 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.86 across 5 years, with a median of 0.79 in 2024.
• Across the five-year window, Asset Utilization Ratio retreated 9.89% in 2024 and surged 50.01% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.78 in 2022, then gained by 4.5% to 0.81 in 2023, then decreased by 9.89% to 0.73 in 2024, then soared by 50.01% to 1.1 in 2025, then dropped by 1.14% to 1.08 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 1.08 in Q1 2026, 1.1 in Q4 2025, and 1.11 in Q3 2025.